$ABBV with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $ABBV after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
ABBV trade ideas
ABBV - Zero To Five Count And Broken TrendlineOn this monthly chart we see the 0-5 count.
In my framework, the framework of the pitchfork, a 0-5 count means, that whenever 5 is reached, there is a high potential for a turn in the opposite direction, starting a new 0-5 count.
On the monthly chart we also see that the CL was reached, and price seems to get rejected. So far a nice combination with the 0-5 count.
Further more, the Trend line on the daily chart was broken with higher volume, three days in a row. A good confirmation of the move.
Against a short is the fact, that ABBV is in a strong phase compared to the overall market. And the monthly Stochastic has not broken it's average yet.
And because of this AND earnings ahead, my position will be smaller than usual, and I'm loading the boat if after earnings we see more decline in price, combined with price action.
#besmartdonttradeafart
will it make it back above or break the trend support ? ABBV broke below trend support but trying to climb back above! make or break it area!
above 165.15 we can target 170.51-175.88, below 156.47 we can target 152.21-145.95
$ABBV Epic Short in the MakingABBV has been on an epic blast higher and is Vertical off the monthly moving averages. Looking for a round number 180, 200 or into the extreme extension above 210. Shorts should be looking to build a nice position on this with time as it continues to extend. Short back down to the Discount zone.
ABBV due for a major pullbackABBV has benefited from institutional investors plowing into it while they force the rest of the market to fall...My guess is this will fall while they pull their money and buy quality tech at massive discounts. Today's candle looks like a top. Adding puts 3 weeks out.
Abbvie Inc possible reversalThe Abbvie might give a possible bearish pattern so previous buyers can take profit right now. The strategy for short sellers is given in the chart. In case these levels hold and an increase in the price is seen then the buyers can buy it at a later price of 154.
AbbVie | ABBV | Due for a CorrectionAbbVie ( NYSE:ABBV ) looks weak at resistance and may be due for a drop in the coming weeks. Pretty strong bearish divergence. Insiders selling almost $16 million worth of shares in the past month at an average of $147.87 (source: OpenInsider). If this starts to drop, support points are the 50 EMA (yellow line), $135-$136, and then the support lines / 200 EMA. Small gap to fill between $145.70 and $145.76.
New drug approvals or positive company outlook could change this forecast.
$ABBV with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $ABBV after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 100%.
$ABBV ToppingWe broke out of an ascending wedge to an even steep ascending wedge and the RSI even on the monthly chart is oversold.
I see us falling soon, likely to test resistance turned support on the top of the channel at around 120.
2/3/2022 NYSE (ABBV)Buy (Entry Price) above the black line and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price.
Entry Price: $148.09
Target Price: $149.49
Stop Loss: $145.76
Top of the channel.Buffet just released their 13F. The fund dropped all their shares on ABBV and BMY. Both are at the top of the channel. Yellow line is my prediction.
$ABBV - DO NOT FOLLOW JOE TERRANOVA @CNBCJoe just recommended ABBV. Great company, way over valued and he would more likely be selling into your buying. Do not follow these fools.
I am up 20%. Should I fix the profit? Shares not puts.Let's vote. I am for selling and buying back on bounces from support levels. ???
$ABBV - Breaking ATH ? watch for calls > 138.5Weekly outside bar
Holding daily above 21ema
Looks like breaking all time high
Had fun watching this one run.We have a weak market and this one is quite holding up! Would want to see this close above 132-133 for long.
Close below support - Puts.
Im open to any critique. Please feel free to comment and tell me what you think!
AbbVie still bullish. ABBVGaining momentum and impulsing. This is good if you are bullish on this one. COVID paranoia is doing wonders for the pharma sector. It is very rare how a whole sector can benefit so much financially from mass hysteria.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
AbbVie bearish because it is under the curveAbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
stop loss is the blue line
Jaws of death and jaws of wealth.Look for price to eventually reach upper bound resistance $160-165. That would be my exit point.
AbbVie Announces U.S. FDA Granted Breakthrough Therapy DesignatiABBV: AbbVie Inc.
2022-01-04 08:15:00
AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designation (BTD) to Telisotuzumab Vedotin (Teliso-V) for Previously Treated Non-Small Cell Lung Cancer
Exactly What I Look ForShowing exactly what I look for when I make my trades. Experiences traders know what these indicators mean. Message me if you have any questions about any indicators my arrows are pointing at. With this amount of overlapping signs that point towards a price drop is what leads to my confidence in buying my OTM puts and making high returns.
New and veteran subscribers!! It has been a crazy year for me, I am 23 and bought my first house in May and I depleted my stock market funds to put money down on the house. I slowly saved up money to trade but was not smart with my options and took a lot of losses. Definitely in the red for 2021. I got extensive eye surgery months after buying my home, and most recently got a huge promotion at my job in amazon leading to a 100% increase in my salary.
Looking forward to 2022 and have made a personal new years resolution to make at least one publication a week the year of 2022 and looking to only provide the best charts with the most accurate indicators.
I want to wish everyone a happy new year!
